What Does Oxford Immunotec Do?

Total employees129
HeadquartersAbingdon
Founded2001

Oxford Immunotec is a global, high-growth diagnostics company dedicated to developing and commercializing proprietary tests for the management of immune-regulated conditions. Its flagship product, the T-SPOT®.TB test, is a leading method for diagnosing Tuberculosis (TB) infection by measuring T-cell immune response. The company's innovative T-cell measurement technology also finds applications in other areas of immunology, contributing to improved patient care. Since January 2021, Oxford Immunotec has operated as part of PerkinElmer, Inc., benefiting from enhanced global reach, resources, and R&D capabilities within the broader diagnostics landscape.

Where Is Oxford Immunotec's Headquarters?

HQ Function

The UK headquarters serves as the primary center for research and development of its T-SPOT technology, global operations management, manufacturing, and key corporate functions.

Notable Features:

Located within Milton Park, one of Europe's largest science, technology, and business parks, the headquarters benefits from state-of-the-art laboratory and office facilities, fostering an environment of innovation and collaboration.

Work Culture:

The work culture at Oxford Immunotec emphasizes scientific rigor, innovation, and a strong commitment to improving patient outcomes through advanced diagnostic solutions. As part of PerkinElmer, it also aligns with a broader corporate culture focused on global health impact, integrity, and customer focus.

HQ Significance:

Abingdon headquarters is crucial as the origin and central hub for the development and continuous improvement of the company's core T-SPOT technology. It plays a pivotal role in Oxford Immunotec's global strategy, product supply, and scientific leadership.

Values Reflected in HQ: The headquarters' location in a leading science park and its advanced R&D and manufacturing capabilities reflect the company's core values of innovation, scientific excellence, quality, and dedication to addressing critical healthcare needs.

Location:

As a part of PerkinElmer, Oxford Immunotec has a robust global presence, with its products utilized in over 50 countries. Key functions supported globally include sales and marketing, distribution through direct channels and partners, technical and customer support, manufacturing, and ongoing clinical research collaborations. Operations are strategically located in North America, Europe, and Asia to effectively serve diverse healthcare markets worldwide.

Street Address:

143 Milton Park

City:

Abingdon

State/Province:

Oxfordshire

Country:

United Kingdom

Where Else Does Oxford Immunotec Operate Around the World?

Marlborough, Massachusetts, USA

Address: 500 Nickerson Road, Suite 200, Marlborough, MA 01752

To provide dedicated support and market access for Oxford Immunotec's products, particularly the T-SPOT.TB test, within the significant North American healthcare sector.

Tokyo, Japan

Address: Sumitomo Fudosan Hanzomon Ekimae Bldg. 8F, 1-10 Kojimachi, Chiyoda-ku, Tokyo 102-0083

To expand market penetration, ensure regulatory compliance, and provide localized expertise and support for the T-SPOT.TB test and other immunological assays in the Japanese and wider Asia-Pacific healthcare markets.

Buying Intent Signals for Oxford Immunotec

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Oxford Immunotec? Meet the Executive Team

As of April 2025, Oxford Immunotec' leadership includes:

Phill Keefe - Chief Executive Officer, Oxford Immunotec (A PerkinElmer Company)
Dirk Ehlers - President, Diagnostics, PerkinElmer
Prahlad Singh - President and Chief Executive Officer, PerkinElmer (Parent Company)

Who's Investing in Oxford Immunotec?

Oxford Immunotec has been backed by several prominent investors over the years, including:

PerkinElmer, Inc. (Acquirer and Current Owner)
Invesco (Historical Key Investor)
Clarus Ventures (Historical Key Investor)
IP Group / Imperial Innovations (Historical Key Investor)

What Leadership Changes Has Oxford Immunotec Seen Recently?

Hire1
Exits0

Specific executive changes for Oxford Immunotec as a distinct unit are integrated within PerkinElmer's broader Diagnostics division. A notable leadership appointment relevant to Oxford Immunotec within the last 12 months includes Dirk Ehlers taking the helm of PerkinElmer's Diagnostics business.

New Appointments:

Dirk Ehlers, Dirk Ehlers was appointed President, Diagnostics at PerkinElmer, overseeing the division that includes Oxford Immunotec, bringing extensive experience in the diagnostics industry.

What Technology (Tech Stack) Is Used byOxford Immunotec?

Discover the tools Oxford Immunotec uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Oxford Immunotec Email Formats and Examples

Email communication for Oxford Immunotec typically utilizes the company's domain. Common formats include a combination of the employee's first name initial and last name. Given its acquisition by PerkinElmer, some communications might also transition or be affiliated with PerkinElmer's email system, but the oxfordimmunotec.com domain remains active.

[first_initial][last]@oxfordimmunotec.com

Format

jdoe@oxfordimmunotec.com

Example

90%

Success rate

What's the Latest News About Oxford Immunotec?

Business Wire (PerkinElmer Press Release)April 18, 2023

PerkinElmer Launches New T-Cell Select Reagent Kit to Automate Oxford Immunotec's T-SPOT.TB Testing Workflow

PerkinElmer announced the launch of its T-Cell Select™ reagent kit. This kit is designed to automate the sample preparation workflow for Oxford Immunotec's T-SPOT®.TB test, aiming to improve laboratory efficiency, throughput, and standardization in tuberculosis screening....more

GlobeNewswire (PerkinElmer Press Release)April 12, 2023

PerkinElmer to Present New Data on Oxford Immunotec's T-SPOT.TB Test and Automation Solutions at ECCMID 2023

PerkinElmer highlighted its plans to present new clinical data and research findings related to Oxford Immunotec's T-SPOT.TB test and associated automation solutions at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, showcasing ongoing commitment to TB diagnostics....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Oxford Immunotec, are just a search away.